AzTrials
AzTrials

ScoliosisNCT02376634

Hypnotherapy in Major Surgical Procedures

A study testing Hypnosis in people with Scoliosis and Pectus Excavatum, run by Nationwide Children's Hospital at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The purpose of this randomized controlled study is to test the feasibility of clinical hypnotherapy as a perioperative intervention for the reduction of pre-operative anxiety, post-operative pain, and other-related symptoms (nausea, vomiting, spasms, length of stay, self mastery) in children undergoing scoliosis… Read more about this study

Who is it for?
Ages 10 to 21 years
Conditions the study is for
Scoliosis, Pectus Excavatum
What is being tested?
Hypnosis
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
Jun 2016to Jul 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 21 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Patients whose health status is American Society of Anesthesiologists (ASA) physical status I to II, aged 10-21, with idiopathic scoliosis or congenital deformity of the chest wall, who are undergoing Nuss procedure/scoliosis repair at the Nationwide Children's hospital.
  • Parents/Guardian willing and able to authorize informed consent
  • Patients willing and able to authorize assent

Who cannot join

  • ASA classification III, IV (children with a chronic or severe disease).
  • Children with neuromuscular disorders
  • Children with developmental delay
  • Patients with preexisting mental illness

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Nationwide Children's Hospital

    Columbus, Ohio, 43205

Other trials in United States

About this study

Official title: The Effectiveness of Clinical Hypnotherapy in Reducing Anxiety and Pain in Major Surgical Procedures (Nuss and Scoliosis Repair)

The purpose of this randomized controlled study is to test the feasibility of clinical hypnotherapy as a perioperative intervention for the reduction of pre-operative anxiety, post-operative pain, and other-related symptoms (nausea, vomiting, spasms, length of stay, self mastery) in children undergoing scoliosis repair or Nuss procedure.

Read the detailed description

Participants will be 60 children, aged 10-21, ASA 1 and 2 Classification, with idiopathic scoliosis or congenital deformity of the chest wall, who are undergoing Nuss procedure/scoliosis repair at the Nationwide Children's hospital. The design of this study is a single-blinded randomized controlled trial-comparing pre-operative anxiety, post-operative pain and other related symptoms in two groups of:

Group 1: Receives hypnosis (described below) Plus PCA Group 2: Standard of care (PCA)

Interventions:

Group I) Hypnosis: The hypnosis group will receive a semi-structured intervention by primary investigator. The intervention is somewhat individualized based on the recipients personal characteristics (e.g., age, gender, medical history). The intervention will begin with an "induction" phase during which the participant is guided to relax and to focus their attention on one stimuli. The intervention will then proceed with a "suggestion" phase. Suggestions used in this phase will all be directed toward decreasing the patient's anxiety and post-operative pain. Patients will be taught self-hypnosis to decrease distress and reframe painful experiences.

Group II) Control: This group will receive the standard of care of Nationwide Children's hospital.

Procedures:

  1. Potential participants will be identified through review of the NCH surgery schedule and assessed for eligibility by review of the electronic medical record using the exclusionary criteria listed below.
  2. In order to assure valid data, all anesthetic protocol will be standardized.
  3. All patients will be randomized to the Hypnosis group and control group by another member of the research team based on a randomization table. The patient's group assignment will be placed in a sealed envelope prior to the day of surgery. Only PI can access the envelope prior to the intervention. The PI will only perform the assigned intervention while the research assistant and other health care providers are not present. The research assistant and the peri-operative health care personnel will remain blind to group assignment throughout data collection.
  4. A research assistant will administer a brief assessment of state of anxiety (STAI) that will take the patient at most 5 minutes to complete.
  5. The research assistant will measure patient's blood pressure (BP) and heart rate (HR).
  6. The PI will perform the clinical hypnotherapy intervention and teach self-hypnosis at two points of time in Hypnosis group;
  7. In pre-op visit prior to the surgery date
  8. on the day of, prior to the procedure
  9. A second research assistant will administer a second brief assessment of anxiety (STAI), and measure HR and BP again.
  10. Once the patient enters the operating room the standardized anesthetic protocol ( as describe below) will be employed.
  11. Following surgery, in the Post Anesthesia Care Unit (PACU) and floors we standardize pain management with PCA orders.
  12. Postoperative analgesia will be provided by hydromorphone delivered via a patient-controlled analgesia (PCA) device with a bolus dose of 4-8 µg/kg and a lockout period of 8-10 minutes. This may be increased up to 10 µg/kg as needed to achieve optimal analgesia. No basal infusion will be administered for the PCA. The nursing staff in post-anesthesia recovery unit and study staff collecting post-operative pain scores until 24 hours post-operatively will be blinded as to the group assigned. The subject's pain scores will be collected and recorded using the Visual Analogue Scale (VAS) pain scale. Total opiate consumption in the first 24 hours will be recorded. The need for medications to treat opiate-related side effects including naloxone or ondansetron for pruritus or nausea respectively will be recorded. We will record the number of deliveries and demands from the PCA device. We will also record the length of hospital stay.

Measures

  • State-Trait Anxiety Inventory (STAI)15. The STAI, completed by the patient to chart their own anxiety level, is a 40-item self-report measure that contains 20 items measuring state anxiety and 20 items measuring trait anxiety. Subjects are asked to respond on a 4-point Likert scale. Total scores for state and trait portions separately range from 20 to 80, with higher scores denoting higher levels of anxiety.
  • Visual Analog Scale (VAS) The VAS is completed by the blind observer to chart their own rating of the patient's pain. It is a 10cm line where the observer can mark a line anywhere from "not anxious at all" to "very anxious"
  • McGill Pain Questionnaire (MPQ). Sensory and effective dimensions of pain are measured using the short MPQ, which consists of 15 pain descriptors that are rated on a 4-point severity scale from 0 (none) to 3 (severe).
  • Analgesic consumption. Analgesic consumption will be measured by recording the analgesics administered to the study subjects.
  • Clinical recovery. Postoperative parameters will be recorded including time to clear fluid intake, voiding, and discharge from the hospital. The incidence of post-operative complications, such as post-operative nausea and vomiting and post-operative infections, will be noted as well.
  • Global health questionnaire (GHQ). The GHQ is used to assess post-operative recovery; items include sleep, strength and energy, self-assistance and movement. The subjects rate every item on a six point Likert scale. The individual ratings are summed for a total recovery score.
Being tested
Hypnosis
Medical subject headings
Scoliosis, Funnel Chest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HypnosisBehavioural

    Patients will be taught self-hypnosis.

Study groups in NCT02376634
Study groupRoleWhat they receive
HypnosisActive comparatorThe hypnosis group will receive a semi-structured intervention by primary investigator. The intervention is somewhat individualized based on the recipients personal characteristics (e.g., age, gender, medical history). The intervention will begin with an "induction" phase during which the participant is guided to relax and to focus their attention on one stimuli. The intervention will then proceed with a "suggestion" phase. Suggestions used in this phase will all be directed toward decreasing the patient's anxiety and post-operative pain. Patients will be taught self-hypnosis to decrease distress and reframe painful experiences.
Receives: Behavioral: Hypnosis
ControlNo interventionThis group will receive the standard of care of Nationwide Children's Hospital.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pre-operative anxiety

    The STAI, completed by the patient to chart their own anxiety level, is a 40-item self-report measure that contains 20 items measuring state anxiety and 20 items measuring trait anxiety. Subjects are asked to respond on a 4-point Likert scale. Total scores for state and trait portions separately range from 20 to 80, with higher scores denoting higher levels of anxiety.

    Measured: Day of surgery, just prior to the procedure

  2. Post-operative pain

    Total opiate consumption in the first 24 hours will be recorded.

    Measured: 24 hours post-op

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2015 (estimated)
  2. Study startJun 2016
  3. Primary completionJul 2016
  4. Study completionJul 2016

Why it stopped: PI left Nationwide Children's Hosp.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02376634
Sponsor's protocol ID
IRB14-00837
Status last verified
Jul 2016
First submitted
25 Feb 2015
Last updated
9 Sep 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Hypnosis in people with Scoliosis and Pectus Excavatum, run by Nationwide Children's Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 9 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pre-operative anxiety (time frame: Day of surgery, just prior to the procedure). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in